Anuncio
Anuncio

BOLD

BOLD logo

Boundless Bio, Inc. Common Stock

1.31
USD
Patrocinado
0.00
+0.38%
09 ene, 15:59 UTC -5
Cerrado
exchange

Post-mercado

1.35

+0.03
+2.59%

Informes de beneficios de BOLD

Ratio de Sorpresa Positivo

BOLD superó 4 de las últimas 7 estimaciones.

57%

Próximo informe

Fecha del próximo informe
23 mar 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.53
Cambio implícito desde Q3 25 (Revenue/ EPS)
--
/
-14.52%
Cambio implícito desde Q4 24 (Revenue/ EPS)
--
/
-28.38%

Boundless Bio, Inc. Common Stock earnings per share and revenue

On 05 nov 2025, BOLD reported earnings of -0.62 USD per share (EPS) for Q3 25, missing the estimate of -0.59 USD, resulting in a -4.34% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -3.08% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 analistas forecast an EPS of -0.53 USD, with revenue projected to reach -- USD, implying an reducir of -14.52% EPS, and aumentar of 0.00% in Revenue from the last quarter.
Preguntas frecuentes
For Q3 2025, Boundless Bio, Inc. Common Stock reported EPS of -$0.62, missing estimates by -4.34%, and revenue of $0.00, 0% as expectations.
The stock price moved down -3.08%, changed from $1.30 before the earnings release to $1.26 the day after.
The next earning report is scheduled for 23 mar 2026.
Based on 5 analistas, Boundless Bio, Inc. Common Stock is expected to report EPS of -$0.53 and revenue of -- for Q4 2025.
Cheque FXEmpire's Earnings Calendar for today's list of reporting companies.
Anuncio